Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Jorkasky

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Toxicology Letters|February 18, 1999
What does the clinician want to know from the toxicologist?D K Jorkasky
Seminars in Nephrology|March 1, 1988
Drug-induced tubulo-interstitial nephritis: special casesD K Jorkasky, I Singer
Annals of Internal Medicine|July 1, 1986
Long-term renal function in kidney donors: a comparison of donors and their siblingsS L Williams, J Oler, D K Jorkasky
Biochemical and Biophysical Research Communications|June 8, 1973
Reversible inactivation of avian lysozymes by dimethyl (2-hydroxy-5-nitrobenzyl)-sulfonium bromideD K Jorkasky, S E Pearson, C L Borders
Biochemical and Biophysical Research Communications|October 6, 1972
Quantitative analysis of tryptophan modified by 2-hydroxy-5-nitrobenzyl reagents after hydrolysis with p-toluenesulfonic acidC L Borders, D K Jorkasky, S E Pearson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adultsS C Boike, B Ilson, N Zariffa, et al.
Journal of Clinical Immunology|March 1, 1988
Natural killer-cell activity in cyclosporine-treated renal allograft recipientsM Lefkowitz, J Kornbluth, J E Tomaszewski, et al.
Thrombosis and Haemostasis|October 1, 1994
Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonistM I Freed, S Boike, N Zariffa, et al.
Clinical Therapeutics|May 20, 1998
Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapyD E Wilson, K Kaidbey, S C Boike, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Systemic exposure to rosiglitazone is unaltered by foodM I Freed, A Allen, D K Jorkasky, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Toxicology Letters|February 18, 1999
What does the clinician want to know from the toxicologist?D K Jorkasky
Seminars in Nephrology|March 1, 1988
Drug-induced tubulo-interstitial nephritis: special casesD K Jorkasky, I Singer
Annals of Internal Medicine|July 1, 1986
Long-term renal function in kidney donors: a comparison of donors and their siblingsS L Williams, J Oler, D K Jorkasky
Biochemical and Biophysical Research Communications|June 8, 1973
Reversible inactivation of avian lysozymes by dimethyl (2-hydroxy-5-nitrobenzyl)-sulfonium bromideD K Jorkasky, S E Pearson, C L Borders
Biochemical and Biophysical Research Communications|October 6, 1972
Quantitative analysis of tryptophan modified by 2-hydroxy-5-nitrobenzyl reagents after hydrolysis with p-toluenesulfonic acidC L Borders, D K Jorkasky, S E Pearson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adultsS C Boike, B Ilson, N Zariffa, et al.
Journal of Clinical Immunology|March 1, 1988
Natural killer-cell activity in cyclosporine-treated renal allograft recipientsM Lefkowitz, J Kornbluth, J E Tomaszewski, et al.
Thrombosis and Haemostasis|October 1, 1994
Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonistM I Freed, S Boike, N Zariffa, et al.
Clinical Therapeutics|May 20, 1998
Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapyD E Wilson, K Kaidbey, S C Boike, et al.
European Journal of Clinical Pharmacology|April 17, 1999
Systemic exposure to rosiglitazone is unaltered by foodM I Freed, A Allen, D K Jorkasky, et al.
Pageof 6